Literature DB >> 14740179

Relation of coronary vasoreactivity and coronary calcification in asymptomatic subjects with a family history of premature coronary artery disease.

Christian Pirich1, Alexander Leber, Andreas Knez, Frank M Bengel, Stephan G Nekolla, Ralph Haberl, Markus Schwaiger.   

Abstract

Electron-beam computed tomography (EBCT) allows non-invasive imaging of coronary calcification and has been promoted as a screening tool for coronary artery disease (CAD) in asymptomatic high-risk subjects. This study assessed the relation of coronary calcifications to alterations in coronary vascular reactivity by means of positron emission tomography (PET) in asymptomatic subjects with a familial history of premature CAD. Twenty-one subjects (mean age 51+/-10 years) underwent EBCT imaging for coronary calcifications expressed as the coronary calcium score (CCS according to Agatston) and rest/adenosine-stress nitrogen-13 ammonia PET with quantification of myocardial blood flow (MBF) and coronary flow reserve (CFR). The mean CCS was 237+/-256 (median 146, range 0-915). The CCS was <100 in eight subjects and >100 units in 13. As defined by age-related thresholds, 15 subjects had an increased CCS (>75th percentile). Overall mean resting and stress MBF and CFR were 71+/-16 ml 100 g(-1) min(-1), 218+/-54 ml 100 g(-1) min(-1) and 3.20+/-0.77, respectively. Three subjects with CCS ranging from 114 to 451 units had an abnormal CFR (<2.5). There was no relation between CCS and resting or stress MBF or CFR ( r=0.17, 0.18 and 0.10, respectively). In asymptomatic subjects a pathological CCS was five times more prevalent than an abnormal CFR. The absence of any close relationship between CCS and CFR reflects the fact that quantitative myocardial perfusion imaging with PET characterises the dynamic process of vascular reactivity while EBCT is a measure of more stable calcified lesions in the arterial wall whose presence is closely related to age.

Entities:  

Mesh:

Year:  2004        PMID: 14740179     DOI: 10.1007/s00259-003-1426-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  38 in total

Review 1.  ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing).

Authors:  R J Gibbons; G J Balady; J W Beasley; J T Bricker; W F Duvernoy; V F Froelicher; D B Mark; T H Marwick; B D McCallister; P D Thompson; W L Winters; F G Yanowitz; J L Ritchie; R J Gibbons; M D Cheitlin; K A Eagle; T J Gardner; A Garson; R P Lewis; R A O'Rourke; T J Ryan
Journal:  J Am Coll Cardiol       Date:  1997-07       Impact factor: 24.094

2.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

Authors:  G D Hutchins; M Schwaiger; K C Rosenspire; J Krivokapich; H Schelbert; D E Kuhl
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

3.  Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients.

Authors:  R Haberl; A Becker; A Leber; A Knez; C Becker; C Lang; R Brüning; M Reiser; G Steinbeck
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

4.  Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events.

Authors:  N D Wong; J C Hsu; R C Detrano; G Diamond; H Eisenberg; J M Gardin
Journal:  Am J Cardiol       Date:  2000-09-01       Impact factor: 2.778

5.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

6.  A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation.

Authors:  V Schächinger; M B Britten; M Elsner; D H Walter; I Scharrer; A M Zeiher
Journal:  Circulation       Date:  1999-10-05       Impact factor: 29.690

7.  Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study.

Authors:  D B Simons; R S Schwartz; W D Edwards; P F Sheedy; J F Breen; J A Rumberger
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

8.  Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population.

Authors:  R S Blumenthal; D M Becker; T F Moy; J Coresh; L B Wilder; L C Becker
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

9.  Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin.

Authors:  M Guethlin; A M Kasel; K Coppenrath; S Ziegler; W Delius; M Schwaiger
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  8 in total

1.  Coronary artery calcification and vascular function.

Authors:  Sharmila Dorbala; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

2.  Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Lu Wang; Michael Jerosch-Herold; David R Jacobs; Eyal Shahar; Robert Detrano; Aaron R Folsom
Journal:  J Am Coll Cardiol       Date:  2006-08-17       Impact factor: 24.094

Review 3.  The incremental value of coronary artery calcium scores to myocardial single photon emission computer tomography in risk assessment.

Authors:  Marcus Hacker; Christoph Becker
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

4.  Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging.

Authors:  Zelmira Curillova; Bettina F Yaman; Sharmila Dorbala; Raymond Y Kwong; Arkadius Sitek; Georges El Fakhri; Constantinos Anagnostopoulos; Marcelo F Di Carli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-22       Impact factor: 9.236

5.  Cardiac (82)Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes.

Authors:  Bernt J von Scholten; Philip Hasbak; Thomas E Christensen; Adam A Ghotbi; Andreas Kjaer; Peter Rossing; Tine W Hansen
Journal:  Diabetologia       Date:  2015-11-02       Impact factor: 10.122

6.  Quantitative relationship between coronary artery calcium score and hyperemic myocardial blood flow as assessed by hybrid 15O-water PET/CT imaging in patients evaluated for coronary artery disease.

Authors:  Ibrahim Danad; Pieter G Raijmakers; Yolande E Appelman; Hendrik J Harms; Stefan de Haan; Koen M Marques; Cornelis van Kuijk; Cornelis P Allaart; Otto S Hoekstra; Adriaan A Lammertsma; Mark Lubberink; Albert C van Rossum; Paul Knaapen
Journal:  J Nucl Cardiol       Date:  2011-11-11       Impact factor: 5.952

7.  Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET.

Authors:  Thomas H Schindler; Xiao-Li Zhang; John O Prior; Jerson Cadenas; Magnus Dahlbom; James Sayre; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-03       Impact factor: 10.057

8.  Coronary artery and thoracic aorta calcification is inversely related to coronary flow reserve as measured by ⁸²Rb PET/CT in intermediate risk patients.

Authors:  Jongho Kim; Paco E Bravo; Ali Gholamrezanezhad; Seil Sohn; Ash Rafique; Arlene Travis; Josef Machac
Journal:  J Nucl Cardiol       Date:  2013-03-07       Impact factor: 5.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.